Weve officially moved beyond the era of medications that only target one hormone (like Saxenda and Wegovy) and entered a new world of multi-hormone targeting
This review summarizes the clinical outcomes, mechanistic data, formulation considerations, and realistic performance benchmarks of copper peptides for cosmetic use
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016
Oral delivery of nucleic acid therapeutics: challenges, strategies, and opportunities
Intracarpal canal pressures: the role of finger, hand, wrist and forearm position
For instance, a large network meta-analysis showed that SGLT-2 inhibitors reduced hospitalization for HF and renal composite outcome more than GLP-1RA [15], and that in patients with cardiovascular disease, SGLT-2 inhibitors show significant reduction in both heart failure (HF) hospitalizations and mortality for patients with HF and reduced ejection fraction [16]